PROWESS Trial
(Last Updated - 12/12/2010)
"Efficacy And Safety Of Recombinant Human Activated Protein C For Severe Sepsis"
NEJM: 3/8/2001 - Volume 344(10): Pages 699-709.
Serious bleeding: 3.5% (during infusion period) vs. 2.0% (placebo)
Serious Bleeding Defined As:
-ICH
-Life-threatening bleed
-Any bleed requiring 3 units PRBC's
NNH: 1/66
==============================================
References: